Virtual Biopsy Market CAGR To Reach 14.47% by 2035, Due to Growing Demand for Non Invasive Diagnostic Tools| Roots Analysis

According to our latest market report "Virtual Biopsy Market by Target Therapeutic Area, Type of Cancer Targeted, Type of Imaging Technology, End Users and Geographical Regions: Industry Trends and Global Forecasts, till 2035", the virtual biopsy market size is projected to reach USD 3.02 billion by 2035 from USD 0.78 billion in 2025, growing at a CAGR of 14.47% in the forecast period till 2035.

Biopsy procedure has been considered as the most critical tool for disease diagnosis and treatment planning. This technique is performed by extracting tissue samples from patients via incision or surgery, followed by slicing sample acquired into thin slices for staining, microscopic examination and biochemical testing. Despite its widespread applications in patient care management, conventional biopsy procedures have several limitations, including high surgical costs, pain and discomfort experienced by patients due to their invasive nature.

To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/virtual-biopsy-market/request-quote.html

Additionally, it can lead to severe complications, such as hemorrhages and infections caused by incisions. These aforementioned limitations have driven advancements in diagnostic tools, aiming to provide cost effective, non-invasive alternatives for effective screening and disease detection. Several innovations were observed which aimed to provide enhanced patient care, such as emergence of virtual biopsy technique which eliminated the need for surgeries and supports rapid result generation. The virtual biopsy utilize several imaging technologies, including magnetic resonance imaging (MRI), ultrasound and computed tomography (CT) to collect images of patient samples. These images are then processed and analyzed using advanced machine learning and artificial intelligence-integrated software for rapid and efficient interpretation of the disorders. This detailed analysis enables physicians to make informed and accurate decisions for further treatment planning.

To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/virtual-biopsy-market/request-sample.html

Virtual Biopsy Market Segments
Based on target therapeutic area, the market is segmented into oncological disorders, neurological disorders, cardiovascular disorders, ophthalmological disorders, endocrine disorders, gastrointestinal disorders and others.

1. The oncological disorders segment has led the virtual biopsy market, capturing largest revenue share of more than 25% in the current year.
2. The ophthalmological disorders segment is anticipated to show a higher growth rate of 13.49%, during the forecast period.

Based on type of cancer targeted, the market is segmented into solid malignancies, breast cancer, lung cancer, prostate cancer, colorectal cancer, brain cancer and others.

1. The solid malignancies segment has led the virtual biopsy market, capturing largest revenue share of around 35% in the current year.
2. The prostate cancer segment is anticipated to show a higher growth rate of 12.19%, during the forecast period.

Based on the type of imaging technology, the market is segmented into magnetic resonance imaging, computed tomography, X-ray, ultrasound and others.

1. The magnetic resonance imaging segment has led the virtual biopsy market, capturing largest revenue share of more than 30% in the current year.
2. The ultrasound segment is anticipated to show a higher growth rate of 12.39% during the forecast period.

Based on end users, the market is segmented into hospitals and clinics, research institutes and diagnostic centers, and others.

1. The hospitals and clinics segment has led the virtual biopsy market, capturing largest revenue share of approximately 70% in the current year.
2. Both hospitals and clinics, and research institutes and diagnostic center segments are anticipated to be the fastest growing segment in this industry, with an annualized rate of 10.56% during the forecast period.

Virtual Biopsy Market Regional Outlook
Based on the key geographical regions, the virtual biopsy market can be segmented into five major regions, including North America, Europe, Asia Pacific, Latin America and Middle East & North Africa. Led by the US, North America is anticipated to capture the majority share of the virtual biopsy market in 2025, and this trend is likely to remain unchanged during the forecast period. Latin America is accounted to be the fastest-growing segment of the market. The growth of the virtual biopsy market in the region is driven by increasing advancements artificial intelligence (AI) and machine learning algorithms which can further be integrated in virtual biopsy devices to offer efficient, rapid and non-invasive data comprehension and accurate result generation.

Key Report Takeaways
1. Presently about 45 virtual biopsy devices are being developed by various players worldwide; around 65% of these devices are developed by small and very small players headquartered in developed regions
2. Magnetic resonance imaging (33%) has emerged as the most widely employed technology for image acquisition purposes, owing to the fact that it uses safe magnetic and radio waves for capturing data
3. In pursuit of building a competitive edge in this field, stakeholders are actively upgrading their existing capabilities and adding new devices in order to enhance their respective product portfolios
4. Close to 50% of the deals have been inked in the last two years, demonstrating a considerable increase in partnership activity during this period; of these, more than 65% partnerships were international deals
5. Given the various benefits of virtual biopsy technique in improving healthcare outcomes, a significant number of investors have provided financial support to the companies, with over USD 425 million invested since 2020
6. Around 85 patents related to virtual biopsy have been filed / granted by various industry and non-industry players to protect the intellectual property generated within this field
7. More than 65 publications have been filed by scientists in the field of virtual biopsy globally, focusing on recent technological advancements that contribute to the development of efficient healthcare tools
8. The market opportunity associated with virtual biopsy is likely to witness an annualized growth rate of 14.47% till 2035, owing to the growing demand for non-invasive and safer diagnostic tools

Virtual Biopsy Market Key Players
Examples of key companies engaged in virtual biopsy market (which have also been profiled in this market report; the complete list of companies is available in the full report) include City Imaging and Clinical Labs, GE HealthCare, ImageBiopsy Lab, Imaging Biometrics (Acquired by IQ-AI), Median Technologies, OptoVibronex, Quibim, and Siemens Healthineers.

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/virtual-biopsy-market.html

Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.